- Lobbying
- Lobbying by Johnson and Johnson Services, Inc.
Lobbying Relationship
Bills mentioned
H.R.2359: Safe Cosmetics Act of 2011
Sponsor: Jan Schakowsky (D-Ill.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Paul Kim | Senator Kennedy Director For Health Policy; |
- - | Congressman Waxman counsel; Senator Pryor staff Legislative Director for Representative Sherrod Brown |
Kevin Brennan | Chief of Staff for Representative Rosa DeLauro; |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q4 Report
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to the Medical Device User Fee Program and to FDA regulated medical devices and the Regulation & Reimbursement of Diagnostics, regarding all provisions; issues related to dextromethorphan, pseudoephedrine, regulation of cosmetic productions,
and HR 2359, "Safe Cosmetics Act of 2011".
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate